BC Partners sells stake in Brenntag for €577.5m
BC Partners and co-investors have sold seven million shares in listed German chemicals company Brenntag, reducing their joint stake to 13.6%.
BC Partners, Bain Capital and Goldman Sachs owned shares in Brenntag through investments in Luxembourg-based holding company Brachem Acquisition SCA.
Brachem sold all of its seven million shares at €82.50 per share, reducing its stake to 13.6% of the entire share capital of Brenntag. Goldman Sachs acted as sole bookrunner in the accelerated bookbuilt offering. Following the divestment, Brachem has entered into a 180-day lock-up period.
Brenntag floated in March 2010 on the Frankfurt stock exchange, four years after BC Partners' initial investment in the chemicals company. The initial offering was priced at €50 per share and raised €747.5m. Goldman Sachs, Deutsche Bank, JP Morgan and Bank of America were joint bookrunners in the IPO.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








